Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1997 1
1998 1
2001 5
2002 6
2003 2
2004 5
2005 6
2006 5
2007 6
2008 3
2009 4
2010 3
2011 8
2012 9
2013 6
2014 8
2015 7
2016 9
2017 13
2018 9
2019 4
2020 13
2021 14
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
The conventional dendritic cell 1 subset primes CD8+ T cells and traffics tumor antigen to drive anti-tumor immunity in the brain.
Bowman-Kirigin JA, Desai R, Saunders BT, Wang AZ, Schaettler MO, Liu CJ, Livingstone AJ, Kobayashi DK, Durai V, Kretzer NM, Zipfel GJ, Leuthardt EC, Osbun JW, Chicoine MR, Kim AH, Murphy KM, Johanns TM, Zinselmeyer BH, Dunn GP. Bowman-Kirigin JA, et al. Among authors: dunn gp. Cancer Immunol Res. 2022 Nov 21:CIR-22-0098. doi: 10.1158/2326-6066.CIR-22-0098. Online ahead of print. Cancer Immunol Res. 2022. PMID: 36409838
Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD, Coxon AT, Huang J, Abraham CD, Dowling JL, Leuthardt EC, Dunn GP, Kim AH, Dacey RG, Zipfel GJ, Evans J, Filiput EA, Chicoine MR. Li YD, et al. Among authors: dunn gp. Neurosurg Focus. 2022 Nov;53(5):E8. doi: 10.3171/2022.8.FOCUS22367. Neurosurg Focus. 2022. PMID: 36321291
Survival After Resection of Newly-Diagnosed Intracranial Grade II Ependymomas: An Initial Multicenter Analysis and the Logistics of Intraoperative Magnetic Resonance Imaging.
Yahanda AT, Rich KM, Dacey RG Jr, Zipfel GJ, Dunn GP, Dowling JL, Smyth MD, Leuthardt EC, Limbrick DD Jr, Honeycutt J, Sutherland GR, Jensen RL, Evans J, Chicoine MR. Yahanda AT, et al. Among authors: dunn gp. World Neurosurg. 2022 Aug 23:S1878-8750(22)01187-1. doi: 10.1016/j.wneu.2022.08.077. Online ahead of print. World Neurosurg. 2022. PMID: 36028106
Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response.
Wang AZ, Bowman-Kirigin JA, Desai R, Kang LI, Patel PR, Patel B, Khan SM, Bender D, Marlin MC, Liu J, Osbun JW, Leuthardt EC, Chicoine MR, Dacey RG Jr, Zipfel GJ, Kim AH, DeNardo DG, Petti AA, Dunn GP. Wang AZ, et al. Among authors: dunn gp. Genome Med. 2022 May 10;14(1):49. doi: 10.1186/s13073-022-01051-9. Genome Med. 2022. PMID: 35534852 Free PMC article.
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.
Nayak L, Standifer N, Dietrich J, Clarke JL, Dunn GP, Lim M, Cloughesy T, Gan HK, Flagg E, George E, Gaffey S, Hayden J, Holcroft C, Wen PY, Macri M, Park AJ, Ricciardi T, Ryan A, Schwarzenberger P, Venhaus R, Reyes ML, Durham NM, Creasy T, Huang RY, Kaley T, Reardon DA. Nayak L, et al. Among authors: dunn gp. Clin Cancer Res. 2022 Jun 13;28(12):2567-2578. doi: 10.1158/1078-0432.CCR-21-4064. Clin Cancer Res. 2022. PMID: 35395080 Clinical Trial.
Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma.
Yang PH, Tao Y, Luo J, Paturu M, Lu HC, Ramkissoon S, Heusel JW, Leuthardt EC, Chicoine MR, Dowling JL, Dunn GP, Duncavage E, Dahiya S, Chattherjee AR, Kim AH. Yang PH, et al. Among authors: dunn gp. Neurooncol Adv. 2022 Jan 10;4(1):vdac002. doi: 10.1093/noajnl/vdac002. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35156038 Free PMC article.
146 results